Advertisement

Topics

Wuxi Syder Bio-products Co.,Ltd. Company Profile

20:13 EDT 21st September 2018 | BioPortfolio

Wuxi Syder Bio-Products Co., LTD is a specialized one mainly producing Heat Stable a-Amylase. They devote themselves to making a breakthough in fermentation level, products quality and using effects. In the aspects of managerment, they accept ISO-9002 qua

Location

No.734 Life Tower No.78 Jie Fang Road West
Wuxi
Jiangsu
214043
China

Contact

Phone: 0510-2699868
Fax: 0510-5699968
Email: sales@syder.com


News Articles [214 Associated News Articles listed on BioPortfolio]

WuXi Bio Pays $47 Million to Alter OmniAb Pact with Ligand Pharma

WuXi Biologics paid San Diego's Ligand Pharma $47 million in a single payment to re-negotiate its agreement for use of Ligand's OmniAb platform. Because of the payment, WuXi will not have to pay a per...

WuXi Biologics initiate construction of integrated ADC solution center

Offering end-to-end solutions for biologic products the company has started building the facility in Wuxi city in China

WuXi Biologics, Harbour BioMed in Strategic Mfg. Alliance

WuXi to support the supply of Harbour's products for clinical trials under IND applications

WuXi Biologics’ third site: First batch done, US client next

WuXi Biologics completed its first manufacturing project at its 200,000 sq. ft. facility in Wuxi City earlier this week.

Adagene to Collaborate with WuXi Biologics for Antibody Manufacturing

Adagene, a Suzhou antibody discovery company, formed a strategic collaboration with WuXi Biologics giving WuXi responsibility for process development and manufacturing of Adagene products. Adagene has...

WuXi Biologics to Build $20 Million ADC Facility in Wuxi City

WuXi Biologics has begun construction of a $20 million state-of-the-art integrated biologics conjugate R&D/CDMO center in Wuxi city, China. The company said the 6,000 square meter facility, which ...

WuXi STA, Antengene sign drug development and manufacturing deal

STA Pharmaceutical (WuXi STA), a subsidiary of WuXi AppTec, and Antengene have entered into a partnership for the CMC development and manufacturing of innovative oncology drugs.

WuXi AppTec Approved for $910 Million Shanghai IPO

WuXi AppTec announced a $910 million IPO on the Shanghai exchange for the company's core small-molecule CRO business. China regulators approved WuXi's prospectus in a short seven weeks, indicating tha...

PubMed Articles [774 Associated PubMed Articles listed on BioPortfolio]

Maternal air pollution exposure and preterm birth in Wuxi, China: Effect modification by maternal age.

Numerous studies have investigated prenatal air pollution and shown that air pollutants have adverse effect on birth outcomes. However, which trimester was the most sensitive and whether the effect wa...

Analysis of Arsenic Species in Processed Rice Bran Products Using HPLC-ICP-MS.

The purpose of this study was to compare the content of arsenic species (As(V), monomethylarsonic acid [MMA], As(III), and dimethylarsinic acid [DMA]) in products, such as bran powder and tablets, usi...

Stacked GE trait products produced by conventional breeding reflect the compositional profiles of their component single trait products.

An expanding trend for genetically engineered crops is to cultivate varieties in which two or more single trait products have been combined using conventional breeding to produce a stacked trait produ...

Dietary Intake and Content of Cu, Mn, Fe, and Zn in Selected Cereal Products Marketed in Poland.

This paper aims to verify whether cereal products are a good source of Cu, Mn, Fe, and Zn in the diets of Poles. The study material comprised of 445 cereal products including baked goods, breakfast ce...

Modernizing Regulation of Cosmetic Products: Reintroduction of the Personal Care Products Safety Act.

Clinical Trials [997 Associated Clinical Trials listed on BioPortfolio]

Serological Screening of Gastric Cancer in Wuxi Region

The purpose of this study is to determine whether detection of pepsinogen Ⅰand Ⅱ combined with Helicobacter pylori antibody, so-called ABC method , is fit on gastric cancer screening i...

Gastrointestinal Toleration of Inulin Products

The intake of inulin products has been linked to multiple health benefits which has lead to inulin fortification in food products. The investigators hypothesis that doses of up to 10 gram...

Human Laboratory Study of Smokeless Tobacco Products

With the advent of restrictions on public smoking, the tobacco industry has introduced a variety of novel smokeless tobacco products (NSTP) to allow continued tobacco use. These products t...

Oat Products in the Treatment of Coeliac Disease in Children

In many Northern European countries oat-based products have been used in the dieto-therapy of coeliac disease for many years. The purpose of this study is to evaluate clinical tolerance a...

Safe Water Techniques in Kenya

Consumer preferences for POU technologies vary across consumers and products, and largely determine their adoption and subsequent usage. This is a marketing study that asks which products...

Companies [419 Associated Companies listed on BioPortfolio]

Wuxi syder Bio-products Co., Ltd

Wuxi syder Bio-products Co., Ltd is located at Xishan Economic & Technological Development Zone, Our main products are Syder Brand High Temperature α-amylase, Syder Brand High Conversion Efficien...

Wuxi Syder Bio-products Co.,Ltd.

Wuxi Syder Bio-Products Co., LTD is a specialized one mainly producing Heat Stable a-Amylase. They devote themselves to making a breakthough in fermentation level, products quality and using effects. ...

WuXi PharmaTech (Cayman) Inc.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused co...

WuXi PharmaTech, Ltd.

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused com...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

More Information about "Wuxi Syder Bio-products Co.,Ltd." on BioPortfolio

We have published hundreds of Wuxi Syder Bio-products Co.,Ltd. news stories on BioPortfolio along with dozens of Wuxi Syder Bio-products Co.,Ltd. Clinical Trials and PubMed Articles about Wuxi Syder Bio-products Co.,Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Wuxi Syder Bio-products Co.,Ltd. Companies in our database. You can also find out about relevant Wuxi Syder Bio-products Co.,Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record